Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Age With SARS-CoV-2 Antibody Response
He S. Yang, Victoria Costa, Sabrina Racine‐Brzostek, et al.
JAMA Network Open (2021) Vol. 4, Iss. 3, pp. e214302-e214302
Open Access | Times Cited: 204

Showing 1-25 of 204 citing articles:

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial
Bihua Han, Yufei Song, Changgui Li, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 12, pp. 1645-1653
Open Access | Times Cited: 335
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
Timothy A. Bates, Savannah K. McBride, Hans C. Leier, et al.
Science Immunology (2022) Vol. 7, Iss. 68
Open Access | Times Cited: 279
Immunology of SARS-CoV-2 infection in children
Janet Chou, Paul G. Thomas, Adrienne G. Randolph
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 177-185
Open Access | Times Cited: 141
COVID-19 vaccine – Long term immune decline and breakthrough infections
Johad Khoury, Ronza Najjar‐Debbiny, Ayman Hanna, et al.
Vaccine (2021) Vol. 39, Iss. 48, pp. 6984-6989
Open Access | Times Cited: 101
Comparison of Seroconversion in Children and Adults With Mild COVID-19
Zheng Quan Toh, Jeremy Anderson, Nadia Mazarakis, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e221313-e221313
Open Access | Times Cited: 85
Robust and durable serological response following pediatric SARS-CoV-2 infection
Hanna Renk, Alex Dulovic, Alina Seidel, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays
Anton M. Sholukh, Andrew Fioré-Gartland, Emily S. Ford, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 10
Open Access | Times Cited: 86
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders
Céline Louapre, Michella Ibrahim, Élisabeth Maillart, et al.
Journal of Neurology Neurosurgery & Psychiatry (2021) Vol. 93, Iss. 1, pp. 24-31
Open Access | Times Cited: 80
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
Ali Hamady, JinJu Lee, Zuzanna Loboda
Infection (2021) Vol. 50, Iss. 1, pp. 11-25
Open Access | Times Cited: 67
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
Tom Woudenberg, Stéphane Pelleau, François Anna, et al.
EBioMedicine (2021) Vol. 70, pp. 103495-103495
Open Access | Times Cited: 63
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Marloes Grobben, Karlijn van der Straten, Philip J. M. Brouwer, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 63
Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection
Costanza Di Chiara, Anna Cantarutti, Paola Costenaro, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2221616-e2221616
Open Access | Times Cited: 52
Adaptive immunity to SARS-CoV-2 infection: A systematic review
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection—A comparative study from Novi Sad, Serbia
Vladimir Petrović, Vladimir Vuković, Aleksandra Patić, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263468-e0263468
Open Access | Times Cited: 39
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
Mohammad Talaei, Sian Faustini, Hayley Holt, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Understanding COVID-19 in children: immune determinants and post-infection conditions
Gioacchino Andrea Rotulo, Paolo Palma
Pediatric Research (2023) Vol. 94, Iss. 2, pp. 434-442
Open Access | Times Cited: 34
Evaluation of SARS‐CoV‐2 antibody levels on hospital admission as a correlate of protection against mortality
Sylvia Mink, Wolfgang List, Guenter Hoefle, et al.
Journal of Internal Medicine (2023) Vol. 293, Iss. 6, pp. 694-703
Closed Access | Times Cited: 21
The pediatric gut bacteriome and virome in response to SARS-CoV-2 infection
Antonia Piazzesi, Stefania Pane, Federica Del Chierico, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 8
Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients
Orly Haskin, Liat Ashkenazi‐Hoffnung, Noa Ziv, et al.
Transplantation (2021) Vol. 105, Iss. 11, pp. e226-e233
Open Access | Times Cited: 53
Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers
Francesco Bonfante, Paola Costenaro, Anna Cantarutti, et al.
PEDIATRICS (2021) Vol. 148, Iss. 3
Open Access | Times Cited: 51
Surveilling and Tracking COVID-19 Patients Using a Portable Quantum Dot Smartphone Device
Yuwei Zhang, Ayden Malekjahani, Buddhisha Udugama, et al.
Nano Letters (2021) Vol. 21, Iss. 12, pp. 5209-5216
Closed Access | Times Cited: 47
Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece
Anastasia Parthymou, Evagelia E Habeos, George I. Habeos, et al.
BMJ Open (2022) Vol. 12, Iss. 5, pp. e057084-e057084
Open Access | Times Cited: 36
In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from Brazil
Hugo Perazzo, Sandra Wagner Cardoso, Maria Pia Diniz Ribeiro, et al.
The Lancet Regional Health - Americas (2022) Vol. 11, pp. 100244-100244
Open Access | Times Cited: 33
Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
Anisha Misra, Elitza S. Theel
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 6
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top